Akses Pelayanan Rumah Sakit Menjadi Faktor Dominan Kepatuhan Minum Obat pada Penderita Skizofrenia

Authors

  • Lia Sitawati Post Graduate at Health Promotion Departement, Faculty of Public Health University of Indonesia
  • Caroline Endah Wuryaningsih Health Promotion Departement, Faculty of Public Health University of Indonesia
  • Dien Anshari Health Promotion Departement, Faculty of Public Health University of Indonesia

DOI:

https://doi.org/10.26630/jkm.v12i1.1732

Keywords:

Adherence to taking medication, Service access, Paranoid schizophrenia.

Abstract

Background: Schizophrenia is a severe mental disorder. Schizophrenia Aff 21 million people in the world. Household members (ART) in Indonesia who suffer from Schizophrenia / psychosis 6.7 per mile in 2018. Purpose: Know the determinants of adherence to take medication in paranoid Schizophrenia patients in Outpatient Poly Lampung Province Region in 2019. Methods: Quantitative research with cross design sectional. The population is all paranoid schizophrenics who seek treatment at the study site with 192 samples taken using a purposive sampling technique. Data were collected using an interview technique with a questionnaire instrument, then analyzed multivariate with multiple logistic regression tests. Results: There was a significant relationship between income (OR = 4.73), level of education (OR = 19.3), access (OR = 5), perception of family support (OR = 2.2), insight related to disease (OR = 3.5) , perception of disease severity (OR = 2.6), perception of drug side effects (OR = 2.6), perception of the role of the Doctor (OR = 5.7) and the role of the Pharmacist (OR = 2.7). Conclusions: Access to hospital services is a dominant factor in increasing adherence to taking medication in schizophrenics in psychiatric hospitals. Efforts to improve access to sufferers through mental health services in primary care.

References

Acosta et al. (2012). Medication adherence in schizophrenia. World Journal Of Psychiatry, 2(5), 74–78.

Badan Pengawas Obat dan Makan. (2018). Buku informatorium obat Nasional Indonesia (IONI). Retrieved November 12, 2018, from Pusat Informasi Obat Nasional website: http://pionas.pom.go.id/ioni

Bayle, F. J., Tessier, A., Bouju, S., & Misdrahi, D. (2015). Medication adherence in patients with psychotic disorders: An observational survey involving patients before they switch to long-acting injectable risperidone. Patient Preference and Adherence, 9, 1333–1341. Retrieved from https://www.dovepress.com/getfile.php2015416363

Chaudhari et al. (2017). Evaluation of treatment adherence in outpatients with schizoprenia. Industrial Psychiatry Journal, 26(2), 195–201. https://doi.org/10.4103/ipj.ipj

CNN Indonesia. (2018). Penyakit kesehatan kiwa dalam perlindungan BPJS. Retrieved December 19, 2018, from https://www.cnnindonesia.com/gaya-hidup/20181012193101s

Emsley, R., Chiliza, B., Asmal, L., & Harvey, B. H. (2013). The nature of relapse in schizophrenia. BMC Psychiatry, 13, 1–9. Retrieved from http://www.embase.com/search/. http://dx.doi.org/10.1186/1471-244X-13-50

Eticha, T., Teklu, A., Ali, D., Solomon, G., Alemayehu, A., Tareke, M., … Unit, P. (2015). Antipsychotic medication non-adherence among schizophrenia patients in Central Ethiopia. 1–11. https://doi.org/10.1371/journal.pone.0120560

Kaplan & Sadock. (2010). Buku ajar psikiatri Klinis (Edisi 2; H. Muttaqin & R. N. E. Sihombing, Eds.). Jakarta: EGC.

Keefe, R. (2012). Guide to assessment scales in schizophrenia (3rd Editio). London, United Kingdom: Springer Healthcare.

Keliat et al. (2011). Manajemen kasus gangguan jiwa CMHN (Intermediate Course). Jakarta: EGC.

Kemenkes RI. (2013). Riset kesehatan dasar (Riskesdas). Jakarta.

Kemenkes RI. (2014). Rencana aksi kegiatan tahun 2014-2019. Direktorat Bina Kesehatan Jiwa. https://doi.org/.1037//0033-2909.I26.1.78

Kemenkes RI. (2018a). Hasil utama Riset Kesehatan Dasar (Riskesdas) 2018. Kemenkes RI. Jakarta.

Kemenkes RI. (2018b). Laporan Nasional Riset Kesehatan Dasar (Riskesdas) 2018. Jakarta.

Kemenkes RI. (2018c). Pengisian kuesioner Riset Kesehatan Dasar (Riskesdas) 2018.

Kemenkes RI. (2018d). Permenkes No 44 Tahun 2018 tentang penyelenggaraan promosi kesehatan Rumah Sakit. https://doi.org/10.22201/fq.18708404e.2004.3.66178

Noviria, Triyoso, & Yanti, L. (2013). Hubungan dukungan keluarga dengan kunjungan kontrol pasien jiwa Skizofrenia di Rawat Jalan di

RSJ Provinsi Lampung Tahun 2013. Jurnal Kesehatan Holistik, 8(2), 76–81. Retrieved from http://malahayati.ac.id/wp-content/uploads/2016/09/6.-Masnona_Triyoso_Lika.pdf

Rawa, F., Rattu, A. J. M., & Posangi, J. (2017). Faktor-Faktor yang berhubungan dengan kepatuhan minum obat pada penderita skizofrenia di Rumah Sakit Jiwa Prof.DR.V.L. Ratumbuysang Provinsi Sulawesi Utara. Jurnal IKMAS, 1–14. Retrieved from http://www.ejournalhealth.com/index.php

Rumah Sakit Jiwa Provinsi Lampung. (2018). Data kunjungan pasien Rumah Sakit Jiwa Provinsi Lampung.

WHO. (2003). Adherence to long-term therapies, Evidence for Action. Genewa.

WHO. (2017). International statistical classification of diseases and related health problems 10th Revision (ICD-10)-WHO Version for ;2016. Retrieved December 8, 2018, from https://icd.who.int/browse10/2016/en#/F20

WHO. (2018). Fact sheet: schizophrenia. Retrieved from World Health Organization website: http://www.who.int/en/news-room/fact-sheets/detail/schizophrenia

Widyantoro, A. (2003). Faktor-faktor yang berhubungan dengan kepatuhan keluarga penderita skizofrenia membawa keluarganya yang sakit berobat jalan di rumah sakit Jiwa Provinsi Lampung tahun 2003. Tesis Universitas Indonesia. Retrieved from http://www.lontar.ui.ac.id/file?file=pdf/abstrak/id_abstrak-74084.pdf

Yudhantara, D. S., & Istiqomah, R. (2018). Sinopsis skizofrenia untuk Mahasiswa Kedokteran. Malang: UB Press.

Downloads

Published

2018-06-30